Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group
- PMID: 24285698
- PMCID: PMC4190066
- DOI: 10.1002/pbc.24881
Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group
Abstract
Background: Therapy for childhood acute myeloid leukemia (AML) has historically included chemotherapy with or without autologous bone marrow transplant (autoBMT) or allogeneic hematopoietic stem cell transplantation (alloBMT). We sought to compare health-related quality-of-life (HRQOL) outcomes between these treatment groups.
Procedure: Five-year survivors of AML diagnosed before age 21 and enrolled and treated from 1979 to 1995 on one of 4 national protocols were interviewed. These survivors or proxy caregivers completed a health questionnaire and an HRQOL measure.
Results: Of 180 survivors, 100 were treated with chemotherapy only, 26 with chemotherapy followed by autoBMT, and 54 with chemotherapy followed by alloBMT. Median age at interview was 20 years (range 8-39). Twenty-one percent reported a severe or life-threatening chronic health condition (chemotherapy-only 16% vs. autoBMT 21% vs. alloBMT 33%; P = 0.02 for chemotherapy-only vs. alloBMT). Nearly all (95%) reported excellent, very good or good health. Reports of cancer-related pain and anxiety did not vary between groups. HRQOL scores among 136 participants ≥14 years of age were similar among groups and to the normative population, though alloBMT survivors had a lower physical mean summary score (49.1 alloBMT vs. 52.2 chemotherapy-only; P = 0.03). Multivariate analyses showed the presence of severe chronic health conditions to be a strong predictor of physical but not mental mean summary scores.
Conclusions: Overall HRQOL scores were similar among treatment groups, although survivors reporting more health conditions or cancer-related pain had diminished HRQOL. Attention to chronic health conditions and management of cancer-related pain may improve QOL.
Keywords: acute myeloid leukemia; bone marrow transplantation; chronic health condition; late effects; pediatric; quality of life.
© 2013 Wiley Periodicals, Inc.
Similar articles
-
Health and risk behaviors in survivors of childhood acute myeloid leukemia: a report from the Children's Oncology Group.Pediatr Blood Cancer. 2010 Jul 15;55(1):157-64. doi: 10.1002/pbc.22443. Pediatr Blood Cancer. 2010. PMID: 20232426 Free PMC article.
-
Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation.Pediatr Blood Cancer. 2014 Feb;61(2):269-75. doi: 10.1002/pbc.24739. Epub 2013 Aug 19. Pediatr Blood Cancer. 2014. PMID: 23955900 Free PMC article.
-
Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.Pediatr Blood Cancer. 2011 Dec 15;57(7):1222-9. doi: 10.1002/pbc.22931. Epub 2010 Dec 22. Pediatr Blood Cancer. 2011. PMID: 22095929
-
Stage-specific application of allogeneic and autologous marrow transplantation in the management of acute myeloid leukemia.Semin Oncol. 1999 Feb;26(1):21-34. Semin Oncol. 1999. PMID: 10073559 Review.
-
Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.Haematologica. 2000 Nov;85(11 Suppl):47-53. Haematologica. 2000. PMID: 11268324 Review.
Cited by
-
Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group.Cancer Med. 2019 Aug;8(9):4454-4464. doi: 10.1002/cam4.2337. Epub 2019 Jun 12. Cancer Med. 2019. PMID: 31190442 Free PMC article. Clinical Trial.
-
Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood.Int J Hematol. 2022 Nov;116(5):787-797. doi: 10.1007/s12185-022-03426-5. Epub 2022 Sep 3. Int J Hematol. 2022. PMID: 36056987
-
Impact of health-related quality of life on pediatric patients who underwent hematopoietic stem cell transplantation in a Colombian institution.Biomedica. 2022 Sep 2;42(3):531-540. doi: 10.7705/biomedica.6403. Biomedica. 2022. PMID: 36122292 Free PMC article. English, Spanish.
-
Patient-reported outcomes in survivors of childhood hematologic malignancies with hematopoietic stem cell transplant.Blood. 2020 May 21;135(21):1847-1858. doi: 10.1182/blood.2019003858. Blood. 2020. PMID: 32243495 Free PMC article.
-
Characterizing pain in long-term survivors of childhood cancer.Support Care Cancer. 2022 Jan;30(1):295-303. doi: 10.1007/s00520-021-06386-4. Epub 2021 Jul 19. Support Care Cancer. 2022. PMID: 34278531
References
-
- Redaelli A, Stephens JM, Brandt S, et al. Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev. 2004;30:103–117. - PubMed
-
- Nesbit ME, Jr, Woods WG. Therapy of acute myeloid leukemia in children. Leukemia. 1992;6(Suppl 2):31–35. - PubMed
-
- Alonzo TA, Wells RJ, Woods WG, et al. Postremission therapy for children with acute myeloid leukemia: The children's cancer group experience in the transplant era. Leukemia. 2005;19:965–970. - PubMed
-
- Smith FO, Alonzo TA, Gerbing RB, et al. Long-term results of children with acute myeloid leukemia: A report of three consecutive phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891. Leukemia. 2005;19:2054–2062. - PubMed
-
- Hale GA, Tong X, Benaim E, et al. Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation. Bone Marrow Transplant. 2001;27:155–162. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical